Global Antibiotic R&D Partnership (GARDP)
@gardp.bsky.social
350 followers 56 following 230 posts
Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR). https://gardp.org/this-is-big/
Posts Media Videos Starter Packs
Pinned
gardp.bsky.social
The @who.int’s updated Global Action Plan on #AMR, due in 2026, represents a pivotal opportunity to reshape the response to AMR.

GARDP calls for focus on four key areas:

1️⃣ Access to antibiotics
2️⃣ Children & newborns
3️⃣ Public-private partnerships
4️⃣ Financing the AMR response

🔗 bit.ly/48NxgV8
GARDP Statement on the Global Action Plan on AMR update | GARDP
In May 2026, the World Health Assembly will consider adoption of an updated World Health Organization (WHO) Global Action Plan on AMR (GAP). The initial action
bit.ly
gardp.bsky.social
📝 Call for abstracts is open for #ACC2026!

Researchers are invited to share their work on #AMR for short talks or poster presentations.

💡 Themes: child & maternal health, stewardship & access, clinical research, AI in health & more.

⏳ Deadline: 14 Nov 2025, 17:00 GMT
🔗 acc-conference.com#posters
gardp.bsky.social
Finally, #BioJapan2025 starts tomorrow!

📍October 8–10 | Pacifico Yokohama

This year, we’re exhibiting again at the Swiss Pavilion (C-60)✨

💡GARDP is tackling drug-resistant bacterial infections. Come visit us to explore new partnerships and collaboration opportunities!

#SwissInnovation #AMR
gardp.bsky.social
🤝 Our team met with Shionogi’s CEO Dr Teshirogi, and Vice Chairperson Ms Sawada, to reaffirm our shared commitment to addressing #AMR.

Since 2022, Shionogi Japan has been collaborating with GARDP to ensure access to its innovative antibiotic in 135 countries worldwide. 💊
gardp.bsky.social
The @who.int’s updated Global Action Plan on #AMR, due in 2026, represents a pivotal opportunity to reshape the response to AMR.

GARDP calls for focus on four key areas:

1️⃣ Access to antibiotics
2️⃣ Children & newborns
3️⃣ Public-private partnerships
4️⃣ Financing the AMR response

🔗 bit.ly/48NxgV8
GARDP Statement on the Global Action Plan on AMR update | GARDP
In May 2026, the World Health Assembly will consider adoption of an updated World Health Organization (WHO) Global Action Plan on AMR (GAP). The initial action
bit.ly
gardp.bsky.social
💬 Dr Jennifer Cohn shared this insight during a session at Keio University in Japan with over 60 participants, including AMR experts, healthcare professionals and students on global AMR countermeasures.
gardp.bsky.social
"Ensuring access to antibiotics in LMICs doesn’t mean compromising stewardship. It means investing in systems – training, diagnostics, guidelines – that enable appropriate use from day one."

– Jennifer Cohn, GARDP
gardp.bsky.social
This week, GARDP joined the PDP Funders Group in Thailand.

Highlights from the visit 👇

🏥 Siriraj Hospital, Mahidol University – Study on #gonorrhoea & chlamydia in pregnant women.

🧬 Bangrak STIs Center – Insights from Thailand’s first gonorrhoea trial in 40 years (zoliflodacin).
gardp.bsky.social
The GARDP team met with Member of the House of Representatives Hirofumi Niki to thank the Japanese Government for its support.

💬 We discussed #AMR, sustainable antibiotic supply and Japan’s role in global health. Dr Niki stressed the importance of public engagement and awareness. 📢
gardp.bsky.social
During our Tokyo visit, we met Ms Akiko Honda, Member of the House of Councillors, to discuss Japan’s role in global health🌍

💬 She underlined the importance of public support to strengthen cooperation, especially on #AMR. We shared how GARDP’s work delivers value to the Japanese public.
gardp.bsky.social
🎤 GARDP team members Alan Hennessy, Renata da Costa, and Dianna Taylor presented at #GAMRIC2025.

Topics:
1️⃣ Discovery & Exploratory Research
2️⃣ Molecular characterization of CRE & CRPA in hospitalized patients from India

Excited to share insights on antibiotic R&D and access!
Reposted by Global Antibiotic R&D Partnership (GARDP)
lifearc.bsky.social
That's a wrap on #GAMRIC2025! See today's highlights over on LinkedIn - t.ly/nr1sV

Thanks to all who attended and we look forward to seeing you again next year for #GAMRIC2026.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social
gardp.bsky.social
The rise in neonatal sepsis caused by drug-resistant bacteria is a major concern.

GARDP is tackling this with our NeoSep clinical trial, currently underway in Africa and launching in Southeast Asia next year, aiming to identify effective antibiotic combinations. 🌍

www.newsweek.com/drug-resista...
Drug-resistant infections in newborns rising across asia
Sydney researchers are calling for updated guidelines and accelerated drug development.
www.newsweek.com
gardp.bsky.social
🤝 The GARDP team visited Japan’s Ministry of Health, Labour and Welfare (International Affairs & Infectious Disease Divisions) to thank the Government of Japan for its support from 2020 to 2025.

💡 It was a chance to look back on our collab in tackling #AMR and discuss future partnership prospects.
gardp.bsky.social
🌍📊 At a roundtable with the GBD Independent Advisory Committee on data shaping global health strategy, Prof. Peter Piot and Prof. Christopher Murray shared insights, joined by Japanese MPs, researchers and foundations.

GARDP’s Dr Peter Beyer and Dr Chieko Ikeda also contributed to the discussion.
gardp.bsky.social
📢 On 18 Nov, Fleming Centre will light up London’s Piccadilly Lights to raise awareness of #AMR.

🩺 Share your story of how #antibiotics made a difference in your life — it could appear on the world’s biggest billboard.

🔗 www.fleminginitiative.org/thank-you-an...
gardp.bsky.social
In a GARDP-led session at the #GAMRIC, Alison Luckey, our Associate Director of Medical Sciences emphasized inclusivity in STI research.
gardp.bsky.social
🗣 Speaking at the #GAMRIC today, David Peterson reminded the AMR community that millions still lack the antibiotics they need.

Fighting #AMR means fighting both resistance and inequity.
gardp.bsky.social
📍 Meet us in person at #GAMRIC2025

Come by, say hello, and learn how we’re driving antibiotic R&D and access for drug-resistant infections.

From neonatal sepsis to STI innovations, we'd love to walk you through our portfolio.
gardp.bsky.social
🔦 Seamus in the spotlight at #GAMRIC.

GARDP’s Seamus O’Brien joined experts today morning to discuss how to close the treatment gap for newborns with drug-resistant infections.
gardp.bsky.social
🔴 Live from London!

GARDP is at the first-ever #GAMRIC.

In his opening remarks for GAMRIC, Seamus O’Brien from GARDP reminded the audience why partnerships matter.

More updates🔜
Reposted by Global Antibiotic R&D Partnership (GARDP)
lifearc.bsky.social
The inaugural Global AMR Innovators Conference (GAMRIC) has begun!

Stay tuned for updates and join the conversation here or on Bluesky using #GAMRIC2025.

@carb-x.bsky.social @escmid.bsky.social @gardp.bsky.social
gardp.bsky.social
👩‍💻 How can #AI transform microbiology?

Join Adrian Egli & Javier Fernández Domínguez at our next #REVIVE webinar to take a closer look at how AI is being used to analyse microbiological data and predict antimicrobial susceptibility.

📅 28 Oct | 17:00 CET
🔗 Register: bit.ly/42nlm0q
gardp.bsky.social
2️⃣ Speaking in the session: Tech Transfers for Medicines and Vaccines

📅Oct 12 | 12:40-13:50 CEST | Hub 1

A discussion on the opportunities and complexities of technology transfer and how to foster ecosystems that ensure sustainable access to medicines and vaccines.

🔗 Register: bit.ly/3IdUfy5